班伯里论坛关于数字精神健康治疗前进道路的共识声明。

David C Mohr, Francisca Azocar, Andrew Bertagnolli, Tanzeem Choudhury, Paul Chrisp, Richard Frank, Henry Harbin, Trina Histon, Debra Kaysen, Camille Nebeker, Derek Richards, Stephen M Schueller, Nickolai Titov, John Torous, Patricia A Areán
{"title":"班伯里论坛关于数字精神健康治疗前进道路的共识声明。","authors":"David C Mohr, Francisca Azocar, Andrew Bertagnolli, Tanzeem Choudhury, Paul Chrisp, Richard Frank, Henry Harbin, Trina Histon, Debra Kaysen, Camille Nebeker, Derek Richards, Stephen M Schueller, Nickolai Titov, John Torous, Patricia A Areán","doi":"10.1176/appi.focus.25023021","DOIUrl":null,"url":null,"abstract":"<p><p>A major obstacle to mental health treatment for many Americans is accessibility: the United States faces a shortage of mental health providers, resulting in federally designated shortage areas. Although digital mental health treatments (DMHTs) are effective interventions for common mental disorders, they have not been widely adopted by the U.S. health care system. National and international expert stakeholders representing health care organizations, insurance companies and payers, employers, patients, researchers, policy makers, health economists, and DMHT companies and the investment community attended two Banbury Forum meetings. The Banbury Forum reviewed the evidence for DMHTs, identified the challenges to successful and sustainable implementation, investigated the factors that contributed to more successful implementation internationally, and developed the following recommendations: guided DMHTs should be offered to all patients experiencing common mental disorders, DMHT products and services should be reimbursable to support integration into the U.S. health care landscape, and an evidence standards framework should be developed to support decision makers in evaluating DMHTs. Reprinted from <i>Psychiatr Serv 2021; 72:677-683</i>, with permission from American Psychiatric Association. Copyright © 2021.</p>","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"23 3","pages":"362-369"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12207506/pdf/","citationCount":"0","resultStr":"{\"title\":\"Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment.\",\"authors\":\"David C Mohr, Francisca Azocar, Andrew Bertagnolli, Tanzeem Choudhury, Paul Chrisp, Richard Frank, Henry Harbin, Trina Histon, Debra Kaysen, Camille Nebeker, Derek Richards, Stephen M Schueller, Nickolai Titov, John Torous, Patricia A Areán\",\"doi\":\"10.1176/appi.focus.25023021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A major obstacle to mental health treatment for many Americans is accessibility: the United States faces a shortage of mental health providers, resulting in federally designated shortage areas. Although digital mental health treatments (DMHTs) are effective interventions for common mental disorders, they have not been widely adopted by the U.S. health care system. National and international expert stakeholders representing health care organizations, insurance companies and payers, employers, patients, researchers, policy makers, health economists, and DMHT companies and the investment community attended two Banbury Forum meetings. The Banbury Forum reviewed the evidence for DMHTs, identified the challenges to successful and sustainable implementation, investigated the factors that contributed to more successful implementation internationally, and developed the following recommendations: guided DMHTs should be offered to all patients experiencing common mental disorders, DMHT products and services should be reimbursable to support integration into the U.S. health care landscape, and an evidence standards framework should be developed to support decision makers in evaluating DMHTs. Reprinted from <i>Psychiatr Serv 2021; 72:677-683</i>, with permission from American Psychiatric Association. Copyright © 2021.</p>\",\"PeriodicalId\":73036,\"journal\":{\"name\":\"Focus (American Psychiatric Publishing)\",\"volume\":\"23 3\",\"pages\":\"362-369\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12207506/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Focus (American Psychiatric Publishing)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1176/appi.focus.25023021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Focus (American Psychiatric Publishing)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1176/appi.focus.25023021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

对许多美国人来说,心理健康治疗的一个主要障碍是可及性:美国面临心理健康提供者的短缺,导致联邦政府指定的短缺地区。虽然数字精神健康治疗(dmht)是常见精神障碍的有效干预措施,但它们尚未被美国卫生保健系统广泛采用。代表卫生保健组织、保险公司和付款人、雇主、患者、研究人员、决策者、卫生经济学家、DMHT公司和投资界的国家和国际专家利益攸关方参加了两次班伯里论坛会议。班伯里论坛审查了dmht的证据,确定了成功和可持续实施的挑战,调查了有助于在国际上更成功实施的因素,并提出了以下建议:应向所有患有常见精神障碍的患者提供指导的DMHT, DMHT产品和服务应可报销,以支持融入美国卫生保健体系,并应制定证据标准框架,以支持决策者评估DMHT。转载自精神病服务2021;72:677-683,获得美国精神病学协会的许可。版权所有©2021。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment.

A major obstacle to mental health treatment for many Americans is accessibility: the United States faces a shortage of mental health providers, resulting in federally designated shortage areas. Although digital mental health treatments (DMHTs) are effective interventions for common mental disorders, they have not been widely adopted by the U.S. health care system. National and international expert stakeholders representing health care organizations, insurance companies and payers, employers, patients, researchers, policy makers, health economists, and DMHT companies and the investment community attended two Banbury Forum meetings. The Banbury Forum reviewed the evidence for DMHTs, identified the challenges to successful and sustainable implementation, investigated the factors that contributed to more successful implementation internationally, and developed the following recommendations: guided DMHTs should be offered to all patients experiencing common mental disorders, DMHT products and services should be reimbursable to support integration into the U.S. health care landscape, and an evidence standards framework should be developed to support decision makers in evaluating DMHTs. Reprinted from Psychiatr Serv 2021; 72:677-683, with permission from American Psychiatric Association. Copyright © 2021.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信